论文部分内容阅读
目的探究阿司匹林联合波立维对进展性脑梗死患者的临床治疗效果。方法 94例进展性脑梗死患者,按照入院的先后顺序将其分为观察组和对照组,每组47例。观察组采用阿司匹林联合波立维治疗,对照组单用阿司匹林进行治疗,比较两组患者的临床疗效。结果治疗后,观察组患者的治疗有效率为89.36%,高于对照组患者的70.21%;观察组神经功能缺损程度评分(NIHSS)低于对照组,差异均具有统计学意义(P<0.05)。结论对于进展性脑梗死患者而言,在采用阿司匹林治疗的同时加入波立维进行抗血小板聚集治疗,有助于临床症状的缓解,其治疗效果良好,具有临床应用价值。
Objective To investigate the clinical effect of aspirin combined with polio on patients with progressive cerebral infarction. Methods Ninety - four patients with progressive cerebral infarction were divided into observation group and control group according to the order of admission, with 47 patients in each group. The observation group treated with aspirin combined with wave-dimensional treatment, the control group was treated with aspirin alone, the clinical efficacy of the two groups were compared. Results After treatment, the effective rate of treatment in the observation group was 89.36%, which was higher than that in the control group (70.21%). The NIHSS in the observation group was lower than that in the control group (P <0.05) . Conclusions For patients with progressive cerebral infarction, adding aspirin and anti-platelet aggregation therapy together with bevacizumab may help to alleviate the clinical symptoms, and the therapeutic effect is good and has clinical value.